OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review
Daniela Malafaia, Hélio M. T. Albuquerque, Artur M. S. Silva
European Journal of Medicinal Chemistry (2021) Vol. 214, pp. 113209-113209
Closed Access | Times Cited: 39
Daniela Malafaia, Hélio M. T. Albuquerque, Artur M. S. Silva
European Journal of Medicinal Chemistry (2021) Vol. 214, pp. 113209-113209
Closed Access | Times Cited: 39
Showing 26-50 of 39 citing articles:
Chromeno[3,4-b]xanthones as First-in-Class AChE and Aβ Aggregation Dual-Inhibitors
Daniela Malafaia, Ana Oliveira, Pedro Alexandrino Fernandes, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4145-4145
Open Access | Times Cited: 14
Daniela Malafaia, Ana Oliveira, Pedro Alexandrino Fernandes, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4145-4145
Open Access | Times Cited: 14
Carbohydrate-derived bicyclic selenazolines as new dual inhibitors (cholinesterases/OGA) against Alzheimer’s disease
Martha Velueta-Viveros, Macarena Martínez‐Bailén, Adrián Puerta, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105983-105983
Closed Access | Times Cited: 10
Martha Velueta-Viveros, Macarena Martínez‐Bailén, Adrián Puerta, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105983-105983
Closed Access | Times Cited: 10
Multitarget Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: An Opportunity or an illusion?
María João Matos
Future Medicinal Chemistry (2021) Vol. 13, Iss. 15, pp. 1301-1309
Closed Access | Times Cited: 11
María João Matos
Future Medicinal Chemistry (2021) Vol. 13, Iss. 15, pp. 1301-1309
Closed Access | Times Cited: 11
Taurine Stabilizing Effect on Lysozyme
Leonardo Mastrella, Paolo Moretti, Silvia Pieraccini, et al.
Life (2022) Vol. 12, Iss. 1, pp. 133-133
Open Access | Times Cited: 8
Leonardo Mastrella, Paolo Moretti, Silvia Pieraccini, et al.
Life (2022) Vol. 12, Iss. 1, pp. 133-133
Open Access | Times Cited: 8
An NMR Toolkit to Probe Amyloid Oligomer Inhibition in Neurodegenerative Diseases: From Ligand Screening to Dissecting Binding Topology and Mechanisms of Action
Alessandro Palmioli, Cristina Airoldi
ChemPlusChem (2024)
Closed Access | Times Cited: 1
Alessandro Palmioli, Cristina Airoldi
ChemPlusChem (2024)
Closed Access | Times Cited: 1
Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer’s Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy
Sheng Li, Rajiv Bhalla
Neurochemical Research (2024) Vol. 49, Iss. 9, pp. 2273-2302
Open Access | Times Cited: 1
Sheng Li, Rajiv Bhalla
Neurochemical Research (2024) Vol. 49, Iss. 9, pp. 2273-2302
Open Access | Times Cited: 1
Drug Discovery Based on Oxygen and Nitrogen (Non-)Heterocyclic Compounds Developed @LAQV–REQUIMTE/Aveiro
Joana L. C. Sousa, Hélio M. T. Albuquerque, Artur M. S. Silva
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1668-1668
Open Access | Times Cited: 3
Joana L. C. Sousa, Hélio M. T. Albuquerque, Artur M. S. Silva
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1668-1668
Open Access | Times Cited: 3
Joint Computational/Cell-Based Approach for Screening Inhibitors of Tau Oligomerization: A Proof-of-Concept Study
Viet Hoang Man, Da Lin, Xibing He, et al.
Journal of Alzheimer s Disease (2022) Vol. 89, Iss. 1, pp. 107-119
Open Access | Times Cited: 3
Viet Hoang Man, Da Lin, Xibing He, et al.
Journal of Alzheimer s Disease (2022) Vol. 89, Iss. 1, pp. 107-119
Open Access | Times Cited: 3
Synthesis and properties of the kojic acid dimer and its potential for the treatment of Alzheimer's disease
Xueyan Liu, Chuanyu Yu, Biling Su, et al.
RSC Medicinal Chemistry (2022) Vol. 14, Iss. 2, pp. 268-276
Open Access | Times Cited: 3
Xueyan Liu, Chuanyu Yu, Biling Su, et al.
RSC Medicinal Chemistry (2022) Vol. 14, Iss. 2, pp. 268-276
Open Access | Times Cited: 3
Anti-Alzheimer’s and Anti-inflammatory Activities of Compounds Isolated from Solanum Mauritianum
Luis Apaza Ticona, Borja García, Marcos Humanes Bastante, et al.
Planta Medica International Open (2022) Vol. 9, Iss. 01, pp. e1-e11
Open Access | Times Cited: 1
Luis Apaza Ticona, Borja García, Marcos Humanes Bastante, et al.
Planta Medica International Open (2022) Vol. 9, Iss. 01, pp. e1-e11
Open Access | Times Cited: 1
The impact of caffeine on tau-tau interaction: LSPR detection, structural modification and molecular dynamics simulation
Reza Yekta, Leila Sadeghi, Sohrab Ahmadi-Kandjani, et al.
Journal of Molecular Liquids (2021) Vol. 338, pp. 115914-115914
Closed Access | Times Cited: 1
Reza Yekta, Leila Sadeghi, Sohrab Ahmadi-Kandjani, et al.
Journal of Molecular Liquids (2021) Vol. 338, pp. 115914-115914
Closed Access | Times Cited: 1
Efecto de la suplementación con vitaminas del complejo B sobre el declive cognitivo en pacientes con enfermedad de Alzheimer. Revisión sistemática y metanálisis
Gustavo Díaz, Luís García Rairán, Valentina Corredor, et al.
Revista Española de Nutrición Humana y Dietética (2023)
Open Access
Gustavo Díaz, Luís García Rairán, Valentina Corredor, et al.
Revista Española de Nutrición Humana y Dietética (2023)
Open Access
Cromeno[3,4-b]xantonas: Novos Inibidores da Acetilcolinesterase e Agregação Beta-amiloide
Daniela Malafaia, Ana Carolina Mascarenhas Oliveira, Pedro Alexandrino Fernandes, et al.
Boletim da Sociedade Portuguesa de Química (2023), pp. 41-41
Open Access
Daniela Malafaia, Ana Carolina Mascarenhas Oliveira, Pedro Alexandrino Fernandes, et al.
Boletim da Sociedade Portuguesa de Química (2023), pp. 41-41
Open Access
Computational Modeling of DYRK1A Inhibitors as Potential Anti-Alzheimer Agents
Eva Serrano‐Candelas, Laureano E. Carpio, Rafael Gozalbes
Neuromethods (2023), pp. 295-324
Closed Access
Eva Serrano‐Candelas, Laureano E. Carpio, Rafael Gozalbes
Neuromethods (2023), pp. 295-324
Closed Access
